Cashu
Danaher’s Leica Biosystems Unveils Advanced Digital Pathology Solutions to Enhance Cancer Diagnostics
9 days ago
Stocks
Health Care
dhr
Danaher
NYSE: DHR
+0.22 (+0.12%)
191.01
USD
At close at Apr 02, 20:34 UTC
Overview
Loading chart...
Key Stats
Market Cap
134.76B
Dividend Yield
0.00%
P/E Ratio
37.29
EPS
5.33
Revenue
23.88B
Avg. Volume
4.39M
About
What does DHR do?
Danaher, headquartered in Washington, D.C., employs 61,000 people and operates in Biotechnology, Life Sciences, and Diagnostics, offering products and services for medical and industrial applications.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.